Anti-Human CD140a Recombinant Antibody(Olaratumab)

Product Information

Catalog Number	YR1233
Product Name	Anti-Human CD140a Recombinant Antibody(Olaratumab)
Molecular Name	Olaratumab
Alias	Anti-CD140a Recombinant Antibody, Research Grade Olaratumab
CAS Number	1024603-93-7
Molecular Weight	154 kDa
Target	CD140a[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	IF, IP, Neut, FuncS, ELISA, FCM
Buffer	PBS, pH7.5
Background	Olaratumab, sold under the brand name Lartruvo, is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha. It was removed from the United States and European Union markets in 2019, due to insufficient proof of its medical advantage (see below "Medical uses").
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price